Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed May 11, 2012 · 10-Q · 41 days after period end · 0001144204-12-028107
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Net Income | -$872.00K | -$705.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed May 11, 2012 · 41 d after period end
